Skip to main content
BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp — Investor Relations & Filings

Ticker · BGLC ISIN · US0906283066 LEI · 549300COYSKRA3Z7E531 US Professional, scientific and technical activities
Filings indexed 138 across all filing types
Latest filing 2026-04-14 Annual Report
Country US United States of America
Listing US BGLC

About BioNexus Gene Lab Corp

https://www.bionexusgenelab.com/

BioNexus Gene Lab Corp. is a biotechnology company that specializes in precision diagnostics and gene-based technologies. The company focuses on the development and commercialization of advanced molecular diagnostics and genetic testing. Its core service involves non-invasive, blood-based dynamic genome screening for the early detection of an individual's susceptibility to certain diseases. Utilizing RNA research and screening facilities, BioNexus aims to identify health risks at their earliest stages to enable proactive health management.

Recent filings

Filing Released Lang Actions
10-K - BioNexus Gene Lab Corp (0001737523) (Filer)
Annual Report FY 2025
2026-04-14 English
8-K - BioNexus Gene Lab Corp (0001737523) (Filer)
Regulatory Filings
2026-03-17 English
8-K - BioNexus Gene Lab Corp (0001737523) (Filer)
Regulatory Filings
2026-02-23 English
8-K Filing
Regulatory Filings
2026-02-03 English
FORM 8-K
Regulatory Filings
2025-12-30 English
FORM 8-K
Regulatory Filings
2025-12-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.